[The treatment of hemolytic disease of the newborn related to ABO feto-maternal incompatibility].
D000017:ABO Blood-Group System; D000745:Anemia, Hemolytic, Congenital / Q000188:drug therapy / Q000628:therapy*; D001787:Blood Group Incompatibility / Q000150:complications*; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic
D000017:ABO Blood-Group System; D011241:Prednisone
Le traitement de la maladie hémolytique du nouveau-né liée àl'incompatibilité foeto-maternelle ABO.